StonvexLoading…
StonvexStonvexStonvexCore line items from APOG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-02-28 | Annual 2025 2025-03-01 | Annual 2024 2024-03-02 | Annual 2023 2023-02-25 |
|---|---|---|---|---|
Revenue | $1.40B | $1.36B | $1.42B | $1.44B |
Operating Income | $84.47M | $118.11M | $133.83M | $125.79M |
Net Income | $54.13M | $85.05M | $99.61M | $104.11M |
EPS (Diluted) | $2.52 | $3.89 | $4.51 | $4.64 |
Total Assets | $1.12B | $1.18B | $884.06M | $915.37M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $39.52M | $41.45M | $37.22M | $19.92M |
Free Cash Flow OCF − CapEx | $95.16M | $89.57M | $160.97M | $57.52M |
Shares Outstanding | 21.22M | 21.42M | 22.09M | 22.22M |